Acute promyelocytic leukemia (APL) is uniquely sensitive to treatment with all-trans retinoic acid (ATRA), which results in the expression of genes that induce the terminal granulocytic differentiation of the leukemic blasts. Here we report the identification of two ATRA responsive genes in APL cells, ID1 and ID2. These proteins act as antagonists of basic helix-loophelix (bHLH) transcription factors. ATRA induced a rapid increase in ID1 and ID2, both in the APL cell line NB4 as well as in primary patient cells. In addition, a strong downregulation of E2A was observed. E2A acts as a general heterodimerization partner for many bHLH proteins that are involved in differentiation control in various tissues. The simultaneous upregulation of ID1 and ID2, and the downregulation of E2A suggest a role for bHLH proteins in the induction of differentiation of APL cells following ATRA treatment. To test the relevance of this upregulation, ID1 and ID2 were overexpressed in NB4 cells. Overexpression inhibited proliferation and induced a G0/G1 accumulation. These results indicate that ID1 and ID2 are important retinoic acid responsive genes in APL, and suggest that the inhibition of specific bHLH transcription factor complexes may play a role in the therapeutic effect of ATRA in APL.
Introduction
In 98% of the cases of acute promyelocytic leukemia (APL), the promyelocytic (PML) gene on chromosome 15 is fused to the retinoic acid receptor a (RARA) gene on chromosome 17 resulting in a PML-RARa fusion protein. PML-RARa may interfere with the normal function of the retinoic acid receptor, a nuclear hormone receptor that acts as a ligand-dependent transcription factor. 1 Several important RARa target genes have been identified that are deregulated by PML-RARa in APL cells including p21 (waf1/Cip1)2-4 and the transcription factors CCAAT/ enhancer-binding-protein-b and -e (C/EBPb and C/EBPe). 5, 6 p21 waf1/Cip1 is a cyclin-dependent kinase inhibitor that is involved in the regulation of the activity of several cyclindependent kinases and in the cell cycle. The C/EBP transcription factors are involved in the regulation of granulocytic differentiation.
Hematopoietic differentiation is controlled by specific combinations of transcription factors. Some of these are expressed in stem cells, such as AML1, whereas others have a more lineagespecific expression pattern. GATA1, PU.1, C/EBPa and C/EBPe are lineage-specific transcription factors that are important in myeloid development. The results of both knockout and expression studies have shown that GATA1 participates in the differentiation of common myeloid progenitors to megakaryocyte/erythroid progenitors, PU.1 is involved in the development of monocytes/macrophages and C/EBPa and C/EBPe have a role in granulopoiesis. These transcription factors may lock lineage commitment decisions irreversibly by autostimulation of their own expression. In addition, they may inhibit the expression of transcription factors that are involved in alternate differentiation routes, as has been described for PU.1 and GATA1. 7 Members of the bHLH family of transcription factors have been implicated in cell fate decisions in many different tissues. For example, the bHLH transcription factors MyoD and myogenin are involved in the development of muscle tissue and during neurogenesis the bHLH protein MASH-1 plays an essential role. 8 As a common theme, tissue-specific bHLH factors form heterodimers with members of the more ubiquitously expressed E-protein bHLH family members E12/47, HEB and E2-2, which are generally considered as promiscuous heterodimerization partners.
ID proteins constitute a separate class of helix-loop-helix (HLH) proteins lacking the basic DNA-binding domain and acting as dominant-negative regulators of bHLH transcription factors by trapping them in heterodimeric complexes which are unable to bind DNA. 8 In addition, ID proteins have been implicated in cell cycle control through direct interaction with the retinoblastoma protein, 9 and by interaction with the centrosome. 10 Recent data indicate the involvement of ID proteins in angiogenesis, metastasis and tumorigenesis. [11] [12] [13] [14] In hematopoiesis, bHLH transcription factors and their dominant-negative regulators, the ID proteins, have been implicated in lymphopoiesis. Constitutive expression of Id1 targeted to pro-B cells in transgenic mice revealed impairment of B lymphocyte development. 15 In addition, several mutations affecting bHLH proteins have been implicated in lymphoid leukemia. Three bHLH family members (SCL/TAL-1, LYL-1 and E2A) are located at the sites of recurrent chromosomal translocation breakpoints in leukemia. The t (1;14) in patients with T-cell acute lymphoblastic leukemia (T-ALL) transposes the SCL gene to the TCR a/d locus on chromosome 14. 16 The t(7;19) in T-ALL involves the LYL-1 gene that is translocated to the TCR b locus. 17 E2A is involved in the t(1;19) that occurs in approximately 25% of the cases of childhood pre-B ALL and results in the generation of an E2A-PBX fusion protein.
30 min on ice. Indirect immunostaining with a monoclonal anti-PML antibody (PG-M3, Santa Cruz Biotechnology, Santa Cruz, CA, USA) showed a microspeckled pattern characteristic for the PML-RARa fusion protein. [19] [20] [21] Cytogenetic analysis showed that all patients were positive for the t(15;17)(q22;q21) chromosome translocation. Patients and NB4 cells 22 were cultured in RPMI 1640 medium (Life Technologies, Gaithersburg, MD, USA) supplemented with 10% fetal calf serum (FCS) and 2 mM glutamine (Life Technologies). The amphotrophic Phoenix cell line (j-NX-A) (kindly provided by Dr GP Nolan, Stanford University Medical Center, Stanford, CA, USA) was cultured in Dulbecco's modified Eagle's medium (DMEM) (Life Technologies) supplemented with 10% FCS and 2 mM glutamine. Cultures were incubated at 371C in a 5% CO 2 completely humidified atmosphere.
Northern blotting
NB4 cells were induced with all-trans retinoic acid (ATRA) (dissolved in ethanol to a stock solution of 10 À3 M, Sigma, St Louis, MO, USA) at a final concentration of 10 À6 M. Total cellular RNA was isolated by guanidinium-isothiocyanate lysis and centrifugation on a 5.7 M CsCl cushion. PolyA þ RNA was isolated from total RNA by using a mRNA purification kit (Pharmacia Biotech, Uppsala, Sweden). In total, 10 mg of total RNA or 1 mg of PolyA þ RNA was size-fractionated by 1% agarose-formaldehyde gel electrophoresis and transferred onto Hybond N þ nylon membranes (Amersham, Buckinghamshire, UK). The filters were prehybridized and hybridized at 651C overnight in phosphate buffer (2 N NaH 2 PO 4 , 2 N Na 2 HPO 4 ), 7% sodium dodecyl sulfate (SDS), 1 mM ethylenediaminetetraacetic acid (EDTA) pH ¼ 8.0 and 1% bovine serum albumine (BSA). DNA probes were labeled with [ 32 P]a-dATP by random primed labeling (Boehringer, Mannheim, Germany). After hybridization, the filters were washed in 0.2 Â SSC/0.2% SDS for 15 min at 651C. Northern blots were hybridized to radiolabeled human ID1 (kindly provided by Dr S Stegman, NKI, Amsterdam, The Netherlands), murine Id2 (kind gift from Dr XH Sun, NYU, New York, NY, USA), human ID3 (kindly provided by Dr JD Norton, Christie CRC Research Centre, Manchester, UK), human ID4 (kindly provided by Dr L Lania, University of Naples 'Federico II', Naples, Italy) and E2A (kindly provided by Dr S Stegman). As a control for equal loading, filters were stripped and hybridized to a 777 bp HindIII-EcoRI human GAPDH fragment.
Western blotting
Nonstimulated and ATRA-stimulated NB4 cells were lysed in RIPA-buffer containing 1% Nonidet P-40 (NP-40), 0.5% natrium-deoxycholaat, 0.1% SDS and protease inhibitor cocktail (Roche Diagnostics, Basel, Switzerland). Total protein lysates (50 mg) and molecular weight markers were separated on 12% (ID1 and ID2) or 7% (E2A) SDS-polyacrylamide gels and electrophoretically transferred onto polyvinylidenefluoride (PVDF) membranes (Bio-Rad, Hercules, CA, USA). Blots were probed with antibodies to ID1 (Z-8), ID2 (C-20) (Santa Cruz Biotechnology) and with anti-human E2A (E12/E47) antibody (BD Biosciences, San Diego, CA, USA). As a control for equal loading, blots were probed with antibodies to Cdc2 p34 (H-297) or to Actin (I-19) (Santa Cruz Biotechnology).
Construction of retroviral vectors
The pLZRS retroviral vector in which the multiple cloning site is linked to the downstream internal ribosomal entry sequence (IRES) and a truncated form of the nerve growth factor receptor (DNGFR) were kindly provided by Dr GP Nolan and Dr MHM Heemskerk, LUMC, Leiden, The Netherlands, respectively. The pLZRS-ID1-IRES-DNGFR was constructed by cloning the human ID1 cDNA sequence into the BamH1/Xho1 site of pLZRS-DNGFR and pLZRS-ID2-IRES-DNGFR was constructed by cloning the human ID2 cDNA sequence into the BamH1 site of pLZRS-DNGFR. The pLZRS-DNGFR and pLZRS-EGFP-IRES-DNGFR were used as control vectors in the experiments. The pLZRS-EGFP-IRES-DNGFR was constructed as follows: pEGFP-C1 was purchased from Clontech Laboratories (Palo Alto, CA, USA) and the EGFP fragment was isolated by BamH1/Not1 digestion. This EGFP fragment was cloned into the BamH1/Not1 site of pcDNA3, isolated by BamH1/Xho1 digestion and subsequently cloned into the BamH1/Xho1 site of pLZRS-DNGFR.
Retroviral supernatants, transduction of NB4 cells and magnetic cell sorting
Retroviral constructs were transfected into j-NX-A cells using the calcium phosphate precipitation method. At 24 h prior to transfection, j-NX-A cells were seeded at 2.8 Â 10 6 cells/ 75 cm 2 . At 16 h after transfection, the medium was replaced with fresh medium. Supernatants were harvested, centrifuged and frozen in aliquots at À801C. For transduction, cells were cultured on retronectin (Takara Bio Inc., Otsu, Shiga 520-2193, Japan)-coated 35 mm Petri dishes together with 2 ml of thawed supernatant for 22 h and then washed with phosphate-buffered saline (PBS) (B Braun Melsungen AG, Melsungen, Germany). The transduction efficiencies, measured by the expression of the marker DNGFR, were analyzed by flow cytometry 1 day after transduction on a Beckman Coulter Cytomics FC 500 (Beckman Coulter, Miami, FL, USA). Transduction efficiencies were between 17 and 21% for all different transduced cells. Expression levels of the DNGFR were followed during a culture period of at least 22 days and revealed that levels did not change during culture. DNGFR expression was detected by using the supernatant of the 20.4 hybridoma (American Type Culture Collection) producing anti-human NGFR antibody. Transduced NB4 cells were isolated by magnetic cell sorting (MACS) on the basis of DNGFR positivity. Flow cytometric analysis of DNGFR expression of the MACS-sorted cells showed a purity of more than 90% in all experiments. Expression of ID1 and ID2 in isolated transduced cells was confirmed by Western blotting.
Colony-forming assay
Clonogenic growth of tranduced and MACS-sorted NB4 cells was measured by plating 800 cells/ml in semisolid (1.2% methylcellulose; Methocel, Fluka Chemie, Buchs, Switzerland) culture medium (Iscove's modified Dulbecco's medium, IMDM, Life Technologies) supplemented with 20% FCS. Where appropriate, ATRA was added to the semisolid medium at final concentrations as indicated in the figure legends. Colonies were counted after 6 days of culture.
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Cellular differentiation and cell cycle characteristics
Differentiation of transduced and MACS-sorted NB4 cells was assessed on May-Grü nwald-Giemsa stained cytospin slides. In addition, the nitroblue-tetrazolium (NBT, Sigma) reduction test was performed as described. 23 The expression of the differentiation-related surface marker CD11c was measured with a phycoerythrin (PE)-conjugated monoclonal antibody (Immunotech, Marseille, France), apoptosis was measured using Annexin-V-Alexa Fluor 647 (Molecular Probes, Eugene, OR, USA). Results were analyzed on a Beckman Coulter Cytomics FC 500 (Beckman Coulter). More than 5 days after transduction and MACS-sorting NB4 cells were stained for DNA by incubation with a hypotonic propidium iodide solution. Bivariate staining for BrdUrd incorporation and DNA content and calculation of the cell cycle time was performed as described previously. 24 Flow cytometric analysis of the results was performed on a Coulter Epics Elite flowcytometer (Beckman Coulter, Miami, FL, USA).
Results

ID1 and ID2 are rapidly induced upon ATRA treatment of APL cells
bHLH transcription factors and their inhibitors, ID proteins, play an important role in the regulation of proliferation and differentiation of various cell types. We assessed the expression of all four ID gene family members (ID1-ID4) in APL cells before and after incubation with 10 À6 M ATRA. Total RNA was isolated from the PML-RARa positive APL cell line NB4 that can be induced to differentiate with ATRA. ID1 and ID2 mRNA levels strongly increased after exposure to ATRA (Figure 1a and b) . ID1 mRNA expression was upregulated within 2 h and returned to undetectable levels at 48 h after ATRA stimulation. ID2 mRNA expression was also upregulated within 2 h but remained elevated and further increased after 48-96 h after stimulation. In contrast, ID3 and ID4 mRNA could not be detected on Northern blots using total RNA (not shown) or polyA þ mRNA (Figure 1c and d, respectively) .
The expression pattern of ID1 and ID2 was confirmed in APL patient cells (Figure 1e and f) . Leukemic cells were freshly isolated from bone marrow of newly diagnosed patients with previously untreated APL and incubated in the presence or absence of ATRA. After culture for various times RNA was isolated. Both ID1 and ID2 mRNA were rapidly induced by ATRA. Figure 1e shows that ID1 was induced within 2 h and declined to undetectable levels after 24 h. ID2 levels remained elevated at 24 h of incubation (Figure 1f) .
In response to ATRA, ID1 and ID2 were also clearly induced at the protein level (Figure 1g and h) . Western blotting demonstrated that ID1 protein levels were increased at 4 and 8 h after ATRA incubation to diminish to almost undetectable levels at 24 h after incubation with ATRA ( Figure 1g ). ID2 protein was induced at 48-96 h after ATRA incubation (Figure 1h ). Thus, ID1 and ID2 mRNA and protein are rapidly upregulated by ATRA in both NB4 as well as fresh APL cells.
E2A is downregulated during ATRA-induced APL cell differentiation
Since ID proteins act as general inhibitors of bHLH transcription factors by inhibiting their binding to DNA, we measured the expression of E2A, a ubiquitously expressed bHLH protein that serves as a promiscuous heterodimerization partner for many more tissue restricted bHLH proteins. Myeloid specific bHLH proteins are not known yet. E2A mRNA was expressed in nonstimulated NB4 cells but was downregulated within 48 h after exposure to ATRA (Figure 2a ). Also at the protein level, E2A expression strongly decreased upon ATRA-induced differentiation (Figure 2b) : within 48 h, E2A protein expression dropped to undetectable levels. The simultaneous downregulation of E2A and upregulation of ID1 and ID2 suggest a strong repression of bHLH transcription factor activity upon differentiation induction of APL cells by ATRA.
ID1 and ID2 inhibit the clonogenic growth of NB4 cells
To determine the biological relevance of this induction pattern, we tested the effect of forced ID1 and ID2 overexpression in Immunobead selection resulted in more than 90% purity in all experiments. Stable enhanced expression of ID1 and ID2 in these cells was confirmed by Western blotting (Figure 3a) . The levels of ID1 and ID2 expression in the transduced cells were comparable to the endogenous levels in NB4 cells after induction with ATRA as determined by Western blotting (data not shown). The effect of ID1 and ID2 expression was analyzed in a colony-forming assay (Figure 3b ). Compared to controltransduced cells, expression of ID1 and ID2 resulted in inhibition of clonogenic growth by 70 and 50%, respectively.
Since PML-RARa requires higher concentrations of ATRA to become active as a transcriptional activator than the normal, unrearranged RARa, 1 we tested whether overexpression of ID1 and ID2 would be sufficient to restore responsiveness of the cells at lower concentrations. Colony-forming assays were performed in the presence of increasing concentrations of ATRA (Figure 3b) . Apart from the reduction of colony numbers, overexpression of ID1 or ID2 did not alter the concentration at which inhibition of colony formation was observed, which remained at between 10 À8 and 3 Â 10 À8 M ATRA for both control and ID1 or ID2 expressing cells.
ID1 and ID2 inhibit the proliferation of APL cells
To explain the inhibitory effect of ID1 and ID2 on colony formation, we compared the growth characteristics and differentiation of ID1-, ID2-and vector-transduced NB4 cells in liquid cultures. To ensure exactly comparable growth conditions, nontransduced and transduced NB4 cells were mixed 1:1, seeded into culture flasks and analyzed at various time intervals afterwards. Proliferation of the transduced and nontransduced cells was analyzed using DNGFR expression to distinguish between the transduced and nontransduced cells (Figure 4) . When empty vector-or EGFP-transduced cells were seeded, the proportion of transduced cells remained constant over a 3-week period, indicating comparable growth rates of transduced and nontransduced NB4 cells. When ID1-or ID2-transduced cells were seeded, a steady decrease of transduced cells was observed (from 50 to 16 and 22%, respectively) during a 3-week culture period. As the transduced cells represent a (Table 1) and did not stain positive in the NBT reduction assay (not shown). Furthermore, apoptosis (as measured by Annexin-V positivity) was not different in ID1-or ID2-transduced cells compared to vector-transduced or nontransduced cells (Table 1) . Together, this indicates that ID1 and ID2 did not induce differentiation or apoptosis of the NB4 cells. In order to analyze cell proliferation parameters in more detail, cells were pulse-labeled with BrdUrd. BrdUrd is incorporated into the DNA during the S phase. Dividing cells are labeled and the transition of these cells through the cell cycle can be monitored. At 0 and 7 h after labeling, BrdUrd/DNA flow cytometry was performed (Figure 5a ). In five independent experiments, no significant difference in the duration of one complete cell cycle between the ID1-(25.6 h73.3), ID2-(22.5 h71.2) and vector-(22.8 h72.4) transduced cells was observed. However, calculation of the percentage of cells in the different phases of the cell cycle indicated that both ID1 and ID2 caused an increase of cells in the G0/G1 phase, from 34.7% (70.9) in the vectortransduced cell populations to 41.6% (71.4) and 38.9% (71.9) in the ID1 and ID2 overexpressing cell populations, respectively (Figure 5b) . Therefore, what we show is that once cells divide to enter mitosis, the cell cycle time of ID1-and ID2-transduced and vector-transduced cells is comparable, whereas the number of cells that are cycling is different. We conclude that ID1 and ID2 increased accumulation of cells in G0/G1 in NB4 cells, without inducing apoptosis or enhancing differentiation.
Discussion
We identified two genes, ID1 and ID2, which are rapidly induced by ATRA in APL cells. In both the NB4 cell line and in freshly isolated patient cells, ATRA induced the expression of these genes within 2 h. ID2 expression remained high and was more enhanced after 48 h of stimulation. In contrast, the expression of ID1 was transient, being downregulated again within 24 h after stimulation. The rapid induction of ID1 and ID2 mRNA expression in NB4 cells by ATRA was not affected by cycloheximide indicating that ID1 and ID2 are direct ATRAresponsive genes (S Van Wageningen, in preparation). One of the main biological actions of ID proteins is their capacity to inhibit the DNA binding by bHLH transcription factor complexes. They bind and inactivate various lineagespecific bHLH proteins as well as their more ubiquitously ID1 and ID2 inhibit APL cell proliferation J Nigten et al expressed heterodimerization partners (E12/47, HEB, E2-2). The four different ID proteins (ID1-ID4) contain a highly conserved HLH domain and are capable of binding to various common partner proteins. 8 In line with this, they were shown to exert similar or redundant biological functions in various experimental models. However, the differential expression of different ID proteins in various tissues indicate different biological functions for each of the ID proteins under normal physiological conditions. 9, 25 Various knockout mice were generated carrying null mutations in the different Id proteins. While no gross abnormalities were observed in Id1 À/À mice, 26 Id2 À/À mice showed retarded growth and high neonatal morbidity. Surviving Id2 À/À mice displayed severely disturbed natural killer cell production and defective peripheral lymphoid organ development. 27 Redundancy of Id protein function was illustrated by the observation that breeding of various single Id gene knockout mice did not produce viable offspring carrying null mutations in two different Id proteins. 25 One of the important bHLH proteins that is inactivated by ID proteins is E2A. E2A is important for lymphoid development and E2A À/À mice show severe defects in early B cell development. 28 In addition, a high incidence of T cell tumors was observed in these mice. 26 In line with this, inhibition of bHLH trancription factors by the ectopic overexpression of Id2 in developing thymocytes led to the rapid development of lymphomas. 29 Further evidence for the antagonistic action of Id and E2A proteins came from studies with E2A/Id1 double knockout mice. Compared to single E2A knockout mice, the double knockout mice survived significantly better. 26 The biological role of E2A may be dependent on the differentiation stage and cell type in which it is expressed. It has been shown to inhibit G1/S progression in various cell types including fibroblasts and early thymocytes. 30, 31 However, E2A was also reported to be highly expressed in proliferating centroblastic B cells 32 and to promote cell cycle progression in other cells as well. 33 This difference might be explained by the presence of different bHLH heterodimerization partners for E12 and E47 in different tissues.
The simultaneous upregulation of ID proteins and downregulation of E2A may represent a dual mechanism to ensure that E2A-dependent transcription is shut-off during differentiation. Alternatively, as various bHLH proteins were shown to be able to bind to DNA in a homodimeric configuration as well, 8 the primary function of ID1 and ID2 induction may be to inhibit E2A-independent homodimeric DNA-binding by more lineage restricted bHLH transcription factor complexes. The decreased expression of E2A in maturing APL cells may be consistent with the extinguished E2A expression in differentiated myeloid cells. 34 The induction of ID proteins during neutrophilic differentiation may be consistent with the reported expression of ID1 and ID2 in various myeloid cell lines, and in primary granulocytes and monocytes. [35] [36] [37] The rapid downregulation of ID1 at later stages after the initial upregulation is striking (Figure 1 ). However, our data suggest that downregulation of ID1 is not a prerequisite for terminal neutrophilic differentiation, as ID1 overexpressing cells did not become resistant to ATRA. This was shown by the inhibition of colony formation (Figure 3b) , and also by the induction of the differentiation marker CD11c and NBT positivity in ID1-transduced NB4 cells after treatment with ATRA, which was comparable to nontransduced cells (data not shown). In various cell types, ID proteins have been characterized as proteins that inhibit differentiation, and overexpression of these proteins has been reported in many different types of tumors. 38 Two distinct pathways have been described coupling ID function directly to promotion of cell cycle progression. One pathway involves the interaction between the retinoblastoma proteins and ID2 and ID4 that leads to the expression of genes required for S phase progression. The second pathway, which is described for ID1, involves the inhibition of the E2A-mediated activation of the cyclin-dependent kinase inhibitor p21 waf1/Cip1 . 9 Our data suggest that during neutrophilic differentiation, ID1 and ID2 have a different role, being associated with the induction of differentiation and accumulation of cells in G0/G1. The combined effects of ATRA on E2A and ID1 and ID2 suggest that the inactivation of specific bHLH transcription factor complexes in immature APL cells is important to allow neutrophilic differentiation. Different models by which such bHLH proteins could act may be suggested. Upregulation of ID proteins would effectively insulate the cell against any bHLH transcription factor, including those that are involved in other (non-neutrophilic) pathways of differentiation. One candidate could be the bHLH protein SCL/TAL-1 that stimulates erythroid differentiation. 39, 40 This would be in line with the observation that ectopic expression of C/EBPa in human CD34 positive cells induced granulocytic differentiation and inhibited erythrocytic differentiation, while strongly inducing ID1 expression in these cells. 41 Potentially, a similar mode of action might be operational at other differentiation pathway crossroads, for instance at the neutrophil-eosinophil branchpoint, as ectopic expression of ID1 inhibited the growth of CD34 positive cord blood cells that were stimulated with IL-5, which induces eosinophilic rather than neutrophilic differentiation (PJ Coffer et al, Blood 2003; 102(11): abstract 49).
Our data show that the mere overexpression of ID1 or ID2 is not sufficient to induce the differentiation of the cells. However, the increased accumulation of cells in G0/G1 might render the cells more sensitive for other differentiation stimuli, similar to what has been suggested for the differentiation of HL-60 cells in response to retinoic acid. 42 We conclude that ID1 and ID2 are two retinoic acid-induced proteins in acute promyelocytic leukemia cells and suggest that the increased accumulation of the leukemic cells in G0/G1 may contribute to the beneficial effect of retinoic acid in the treatment of APL. Furthermore, we suggest that ID and bHLH proteins may have an important role in differentiation branchpoint decisions during myelopoiesis.
